News Biomind Labs Inc.

Stocks

BMND.F

CA0907021012

Biotechnology & Medical Research

End-of-day quote OTC Markets Other stock markets 2026-07-17			5-day change	1st Jan Change
0.0335 ^USD	-29.77%		-63.63%	-70.61%

May. 15	Biomind Labs Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Mar. 31	Biomind Labs Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

All News

Mentions Relevance

May. 15	Biomind Labs Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Apr. 20	Biomind Labs Applauds Landmark Executive Order Accelerating Psychedelic Research and Access in The United States	AQ
Mar. 31	Biomind Labs Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Mar. 31	Biomind Labs Inc. Auditor Raises 'Going Concern' Doubt	CI
Jan. 28	Canadian Investment Regulatory Organization Trade Resumption - BMND	AQ
Jan. 27	Canadian Investment Regulatory Organization Trading Halt - BMND	AQ
Jan. 26	Biomind Labs Inc. announced that it expects to receive CAD 2.52 million in funding	CI
Dec. 03	Biomind Labs Inc. Announces Major Strategic Advancement in the Development of BMND08	CI
Dec. 01	Canadian Investment Regulatory Organization Trade Resumption - BMND	AQ
Nov. 19	Biomind Labs Inc. Appoints Scott Ackerman as an Independent Director of the Board of Directors, and as an Independent Member of the Audit Committee	CI
Nov. 18	Biomind Labs Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-08-13	Biomind Labs Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-08-12	Biomind Labs Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-08-07	Biomind Labs Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-08-06	Biomind Labs Inc. Auditor Raises 'Going Concern' Doubt	CI
25-04-07	Canadian Investment Regulatory Organization Trading Halt - BMND	AQ
24-10-29	Biomind Labs Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-08-14	Biomind Labs Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-08-02	Biomind Labs Inc. to Redefine Obesity Treatment with Its New BMND06 Candidate Targeting Neurological Pathways	CI
24-07-18	Biomind Labs Inc. Announces the Decision to Advance A New Phase II Clinical Trial	CI
24-06-04	Canadian Investment Regulatory Organization Trade Resumption - BMND	AQ
24-05-31	Biomind Labs Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-05-30	Biomind Labs Inc. Auditor Raises 'Going Concern' Doubt	CI
24-04-09	Canadian Investment Regulatory Organization Trading Halt - BMND	AQ
23-09-14	Biomind Labs Completes the Development of the First 5-MeO-DMT Organic Synthesis Scheme for Pharmaceutical Applications	CI